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Background: In the Beta-Blocker Evaluation of Survival Trial (BEST), bucindolol significantly reduced mortality among whites but had no effect 
on African Americans (p for interaction, 0.02) with systolic heart failure (HF). Whether this may in part be due to racial differences in baseline 
characteristics has not been previously examined.
methods: Of the 2,708 BEST patients with chronic advanced systolic HF randomized to receive bucindolol (n=1,354) or placebo (n=1,354), 627 
were African American.
results: African American HF patients were younger (56 vs. 62 years; p <0.001) and more women (29% vs. 19%; p <0.001), which in part 
explained the non-significant unadjusted hazard ratio (HR) for all-cause mortality for African Americans (HR, 1.10; 95% CI, 0.94-1.29; p=0.228), 
which became significant (HR, 1.27; 95% CI, 1.08-1.50; p=0.003) when adjusted for age and sex. This association remained significant after 
multivariable-adjustment including left ventricular ejection fraction (HR, 1.20; 95% CI, 1.01-1.43; p=0.043; Table). However, this association lost 
significance when right ventricular ejection fraction (RVEF) was added into the full model (HR, 1.17; 95% CI, 0.98-1.39; p=0.089) or the age-sex-
adjusted model (HR, 1.15; 95% CI, 0.98-1.36; p=0.093; Table).
conclusions: African Americans with advanced systolic HF in BEST had higher risk of death, which was in part due to their lower RVEF, which may in 
part also explain the lack of mortality benefit among African Americans in BEST (JACC.2011;57:E298).
Association of race with all-cause mortality in BEST during average 2 years of follow-up
Hazard ratio (95%CI) P value
Model 1: unadjusted 1.10 (0.94-1.29) 0.228
Model 2: model 1 + age, sex 1.27 (1.08-1.50) 0.003
Model 3: model 2 + medical historya 1.35 (1.14-1.60) 0.001
Model 4: model 3 + medicationsb 1.29 (1.09-1.53) 0.003
Model 5: model 4 + clinical /laboratoryc 1.20 (1.01-1.43) 0.043
Model 6: model 5 + RVEF 1.17 (0.98-1.39) 0.089
Model 7: age + sex + RVEFd 1.15 (0.98-1.36) 0.093
aSmoking years, duration of HF, NYHA class, acute myocardial infarction, diabetes, hypertension, atrial fibrillation, ventricular fibrillation, 
peripheral vascular disease, chronic kidney disease.
bBucindolol, ACE inhibitor, ARB, digitalis, diuretics.
cBody mass index, heart rate, systolic and diastolic blood pressure, serum sodium, potassium and albumin, and left ventricular ejection fraction.
dAfrican Americans had lower mean RVEF (32% vs 36%; p <0.001).
